1. Home
  2. IFRX vs GWH Comparison

IFRX vs GWH Comparison

Compare IFRX & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFRX
  • GWH
  • Stock Information
  • Founded
  • IFRX 2007
  • GWH 2011
  • Country
  • IFRX Germany
  • GWH United States
  • Employees
  • IFRX N/A
  • GWH N/A
  • Industry
  • IFRX Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • IFRX Health Care
  • GWH Miscellaneous
  • Exchange
  • IFRX Nasdaq
  • GWH Nasdaq
  • Market Cap
  • IFRX 86.0M
  • GWH 87.1M
  • IPO Year
  • IFRX 2017
  • GWH N/A
  • Fundamental
  • Price
  • IFRX $1.77
  • GWH $4.32
  • Analyst Decision
  • IFRX Strong Buy
  • GWH Hold
  • Analyst Count
  • IFRX 5
  • GWH 4
  • Target Price
  • IFRX $9.80
  • GWH $2.67
  • AVG Volume (30 Days)
  • IFRX 6.9M
  • GWH 3.3M
  • Earning Date
  • IFRX 11-07-2025
  • GWH 11-13-2025
  • Dividend Yield
  • IFRX N/A
  • GWH N/A
  • EPS Growth
  • IFRX N/A
  • GWH N/A
  • EPS
  • IFRX N/A
  • GWH N/A
  • Revenue
  • IFRX $73,729.00
  • GWH $6,166,000.00
  • Revenue This Year
  • IFRX N/A
  • GWH $131.04
  • Revenue Next Year
  • IFRX $1,216.24
  • GWH $76.74
  • P/E Ratio
  • IFRX N/A
  • GWH N/A
  • Revenue Growth
  • IFRX N/A
  • GWH N/A
  • 52 Week Low
  • IFRX $0.71
  • GWH $0.76
  • 52 Week High
  • IFRX $2.82
  • GWH $13.87
  • Technical
  • Relative Strength Index (RSI)
  • IFRX 63.15
  • GWH 52.17
  • Support Level
  • IFRX $1.16
  • GWH $3.80
  • Resistance Level
  • IFRX $1.48
  • GWH $4.75
  • Average True Range (ATR)
  • IFRX 0.20
  • GWH 0.55
  • MACD
  • IFRX 0.02
  • GWH -0.13
  • Stochastic Oscillator
  • IFRX 75.64
  • GWH 35.02

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: